Iranian
Biomedical Journal
Volume 30, Issue 1 (1-2026)
IBJ 2026, 30(1): 47-59 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nejat L, hatami M, Adelipour M, Igder S, Rashidi M. Synergistic Reversal of Epithelial–Mesenchymal Transition by Quercetin and 5-Fluorouracil Co-Treatment in Triple-Negative Breast Cancer: Mechanistic Insights into ZEB1 Suppression and E-Cadherin Restoration. IBJ 2026; 30 (1) :47-59
URL: http://ibj.pasteur.ac.ir/article-1-5156-en.html
URL: http://ibj.pasteur.ac.ir/article-1-5156-en.html
Abstract:
Keywords: Quercetin, 5-Fluorouracil, Triple-negative breast cancer (TNBC), Epithelial-mesenchymal transition (EMT), ZEB1 suppression
Type of Study: Full Length/Original Article |
Subject:
Cancer Biology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |